BioHarvest Sciences Inc. Common Stock
NASDAQ:BHSTAgricultural Inputs
+$0.08 today
- Market cap
- $50.25M
- Beta
- 1.33
- P/E (TTM)
- -6.6
- EPS (TTM)
- -$0.50
Volume 0.01M
Average 0.03M
BHST Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
BioHarvest Sciences Inc. Common StockNASDAQ: BHST
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q1 FY2026 depreciation & amortization of $428K rose 7.3% year over year, behind the +14.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 1.2% from the prior quarter. Over 3 fiscal years it compounded at +31.6% a year.
Context
- Depreciation & amortization amounted to 4.7% of revenue in FY2025, down 0.3 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +7.3% toward the trailing-twelve-month pace of +14.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 1.62M USD
- Year-over-year change
- +29.8%
- 4-year CAGR
- +43.3%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.62M | +29.8% |
| FY2024 | 2024-12-31 | 1.25M | +48.9% |
| FY2023 | 2023-12-31 | 840K | +18.0% |
| FY2022 | 2022-12-31 | 712K | +84.7% |
| FY2021 | 2021-12-31 | 385.58K | — |
Depreciation & Amortization vs competitors
How BHST compares with its peers on the latest reported figures
- BHST's LTM Mar 2026 depreciation & amortization of $1.65M is the 8th largest of the 9 companies compared; the peer median is $6.88M.
- Its year-over-year change of +14.2% is the 3rd highest of 8, against a peer median of -6.0%.
- Depreciation & amortization amounts to 4.7% of revenue for BHST, versus a peer median of 4.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $160.43M | -6.0% | +3.5% | 8.7% | |
| LTM Mar 2026 | $18.68M | -14.4% | -5.4% | 3.6% | |
| LTM Mar 2026 | $12.19M | -8.5% | +1.3% | 4.5% | |
| LTM Mar 2026 | $9.89M | +10.8% | -2.6% | 9.0% | |
| LTM Mar 2026 | $3.87M | +17.5% | +14.8% | 0.6% | |
| LTM Mar 2026 | $3.73M | -55.8% | -24.4% | 4.9% | |
| LTM May 2025 | $3.12M | +48.5% | +251.2% | 5.9% | |
| LTM Mar 2026 | $1.65M | +14.2% | +31.6% | 4.7% | |
USGOU.S. GoldMining Inc. | LTM Feb 2026 | $198.69K | — | — | — |
| Peer median (excluding BHST) | $6.88M | -6.0% | +1.3% | 4.9% | |
Competitors are the stored peer set for BHST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (9.83M) | (11.24M) | (12.56M) | (12.91M) | (11.14M) |
| Depreciation & Amortization | 385.58K | 712K | 840K | 1.25M | 1.62M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 3.37M | 1.35M | 563K | 601K | 597K |
| Change in Working Capital | (96K) | (308K) | 755K | (555K) | (1.94M) |
| Accounts Receivables | (266K) | (588K) | (22K) | (594K) | (1.11M) |
| Inventory | (828K) | (450K) | (1.09M) | (1.19M) | (904K) |
| Accounts Payables | 0 | 730K | 0 | 1.04M | 0 |
| Other Working Capital | 998K | 0 | 1.87M | 188K | 67K |
| Other Non-Cash Items | (627K) | 239K | 1.88M | 4.93M | 3.63M |
| Operating Cash Flow | (6.79M) | (9.24M) | (8.52M) | (6.68M) | (7.23M) |
| Capital Expenditures | (1.64M) | (1.26M) | (1.47M) | (2.84M) | (2.36M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (192K) | (10K) |
| Investing Cash Flow | (1.64M) | (1.26M) | (1.47M) | (3.03M) | (2.37M) |
| Debt Repayment | (332K) | 7.3M | 13.15M | 2.04M | 5.25M |
| Common Stock Issued | 7.47M | 877K | 534.17K | 4.33M | 25.1M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 3.64M | (38K) | (131.17K) | 408K | (159K) |
| Financing Cash Flow | 10.77M | 8.14M | 13.56M | 6.78M | 30.19M |
| Effect of Forex Changes | (4K) | (22K) | 59K | (34K) | 39K |
| Net Change in Cash | 2.33M | (2.38M) | 3.62M | (2.97M) | 20.64M |
| Free Cash Flow | (8.43M) | (10.5M) | (10M) | (9.52M) | (9.58M) |
BioHarvest Sciences Inc. Common Stock
NASDAQ:BHST
Intrinsic Alpha fair value
Locked
Current Price
$2.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.